Newly Re-launched Website Helps PhDs and MDs Capitalize on Growth in Life Science ... ( SANTA CRUZ Calif. Sept. 22 /- This mo...)

Newly Re-launched Website Helps PhDs and MDs Capitalize on Growth in Life Science Industries

Date:9/22/2010

SANTA CRUZ, Calif., Sept. 22 /PRNewswire/ -- This month, Bio Careers (www.biocareers.com), formerly Bio Career Center, unveils its newly enhanced website. The updated online platform includes the largest U.S. job board for postgraduates in the life sciences, and an extensive archive of articles and professional development resources.

"While life science employers have not been spared by the recession, we've seen significant job growth," said Nick Folger, founder and president. "Our newly designed site helps candidates capitalize on this growth by offering them high-quality job leads and a wealth of information to help them compete in a competitive market. We're also providing an invaluable service to recruiting offices and university career centers, many of which are stretched thin."

With a founding membership among the nation's most prestigious universities, Bio Careers is the only career service dedicated to expanding professional options for life science PhDs and MDs. The website is partnered with 32 training institutions, and leverages relationships with leading employers to give degree candidates and mid-career level alumni access to high-quality job opportunities. The site's extensive network of life sciences employers include National Institutes of Health (NIH), Food and Drug Administration (FDA), Genentech, LEK Consulting, Mayo Clinic, SAIC-Frederick, PLoS and colleges and universities across the United States.

In addition to the website's robust job search engine, Bio Careers offers industry news, professional development articles, a bookstore and access to self-assessment tests and career tools. Resources cover a variety of topics including launching a new career in science policy, entrepreneurship, biopharma business, venture capital and mid-career growth.

Bio Careers' re-launch includes a life science industries blog, multimedia and social media features and functionality and online
'/>"/>

SOURCE Bio Careers
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
4. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
5. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
6. Newly Approved HIV Drug Shows Great Promise
7. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
8. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
9. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
10. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
11. Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes

Post Your Comments:

(Date:5/24/2013)... , May 24, 2013 Solta Medical, Inc. (NASDAQ: ... aesthetics market, today reported Dr. Edward W. Knowlton ... Board of Directors effective immediately. Dr. Knowlton is the founder ... served as a director since 1996. "On behalf ... management team, I would like to thank Ed for his ...

(Date:5/24/2013)... An international roster of experts on malignant pleural ... Santa Monica, Calif. , to discuss their ... a rare form of cancer that results from exposure ... of the chest. Hosted by UCLA and ... Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural ...

(Date:5/24/2013)... Colo. , May 24, 2013 Heska Corporation (NASDAQ: ... diagnostic and specialty products, announced today that Dr. ... officer, and Jason Napolitano , executive vice ... Annual Marcum MicroCap Conference, which is being held May 30, ... the Grand Hyatt Hotel. The Company,s presentation ...

Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2 International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2 International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3 Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2

[0] Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.[0] International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma [0] Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference

... & MENLO PARK, Calif.--(BUSINESS WIRE)--Jun,4, 2007 - ... the presentation of data from its Quinamed(R),(amonafide ... a genotypically optimised dose of Quinamed in,heavily ... tumors. The,key outcomes from this study were ...

... in Journal Heart Finds Taxus Stent,Implantation of Multiple Stents ... for Another Procedure, , MIAMI LAKES, Fla., ... analysis of data from the Western Denmark Heart,Registry found ... open a clogged artery were less,likely to need another ...

Cached Medicine Technology:ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO 2 ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO 3 ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO 4 New Study Suggests Better Patient Outcomes with CYPHER,Sirolimus-Eluting Coronary Stent than with Taxus Stent in,Real-World Clinical Settings 2 New Study Suggests Better Patient Outcomes with CYPHER,Sirolimus-Eluting Coronary Stent than with Taxus Stent in,Real-World Clinical Settings 3

ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO New Study Suggests Better Patient Outcomes with CYPHER,Sirolimus-Eluting Coronary Stent than with Taxus Stent in,Real-World Clinical Settings

(Date:5/24/2013)... Paris, France: Routinely measuring fractional flow reserve (FFR) ... diagnosis of chest pain leads to significant changes ... according to results from a study reported at ... wire assessment influence management strategy at coronary angiography ... to assess whether routine assessment of FFR in ...

(Date:5/24/2013)... new investigational device - the Helio System (TF-FA) - ... Heart Valve was successfully deployed in all four patients ... in high-risk aortic insufficiency reported at EuroPCR 2013. , ... help stabilise the SAPIEN XT valve for patients with ... captured between the transcatheter heart valve and the dock. ...

(Date:5/24/2013)... valve implantation (TAVI) is effective and safe in Asian ... from a multicentre Asian registry reported at EuroPCR 2013. ... treatment option for selected patients with symptomatic severe aortic ... American or European centres," Paul Chiam, senior consultant cardiologist ... He explained that it is unknown whether the smaller ...

(Date:5/24/2013)... news about youth and diabetes keeps getting worse. The latest ... who develop Type 2 diabetes are at high risk to ... higher rate than people who acquire Type 2 diabetes as ... they seem to be at very high risk for early ... of pediatric endocrinology in the School of Medicine at The ...

(Date:5/24/2013)... discovery at Oregon Health & Science University highlights an ... infected with the highly evasive HIV virus that causes ... this unique approach to develop its own HIV vaccine ... animal studies. This latest research finding will be published ... Science . , "A major challenge in ...

Breaking Medicine News(10 mins):Health News:Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases 2 Health News:Feasibility trial reports deployment of new device for TAVI in aortic insufficiency 2 Health News:Registry confirms TAVI efficacy and safety in Asian patients 2 Health News:Youth with type 2 diabetes at much higher risk for heart, kidney disease 2 Health News:OHSU research highlights promising strategy to help vaccines outsmart HIV 2

[0] Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases [0] Feasibility trial reports deployment of new device for TAVI in aortic insufficiency [0] Registry confirms TAVI efficacy and safety in Asian patients [0] Youth with type 2 diabetes at much higher risk for heart, kidney disease [0] OHSU research highlights promising strategy to help vaccines outsmart HIV

... million, up 7.6% from the first ... quarter of 2007., - Same ... March 31, 2008 over the corresponding period ended in 2007.,- Cash From Facility ... 19% increase over the first period of 2007, and was $0.41 per ...

... drugs that work by blocking brain molecules similar to ... in young children, according to a new study from ... is known to be an appetite stimulant, and a ... Acomplia) developed by Sanofi-Aventis and awaiting approval for use ...

... The American Academy,of Physician Assistants (AAPA), representing ... U.S., is pleased to join other national,organizations ... Treating Tobacco Use and Dependence: 2008 Update., ... even stronger,evidence to support the efforts of ...

... SAO PAULO, Brazil, May 7 Medial Saude S/A,(BOVESPA: MEDI3) (MEDIAL SAUDE) announces the following webcast:, ... When: Thursday, May 8, 2008 @ 12:00 PM EDT, Where: ... Internet -- Simply log on to the web at the ... Conference call dial-in phone numbers: ...

... a Puzzling Pediatric Tumor--, PHILADELPHIA, May 7 ... for the,first time identified a chromosome region that is ... an often fatal childhood cancer., The investigators found ... of chromosome 6 raises the risk that a child ...

... French . , Ottawa (May 7, 2008) ... today funding from the Canadian Institutes of Health Research ... over $298 million. Minister Clement was joined by Dr. ... Po-Yin Cheung, a neonatologist and CIHR-funded researcher from the ...

Brookdale Announces First Quarter 2008 Results MIT study suggests caution on new anti-obesity drug in kids AAPA Endorses 2008 Public Health Service Guidelines for Treating Tobacco Use and Dependence Webcast Alert: Medial Saude S/A Announces First Quarter 2008 Earnings Conference Call Webcast Researchers Find Gene Location That Gives Rise to Neuroblastoma, an Aggressive Childhood Cancer CIHR news: health research touching lives

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

Medicine Products:

T-Cell Immunodeficiency Extended Profile T-Cell Clonality Assessment by Restriction Fragment Southern Blot Hybridization, Fluid Syphilis Antibody, IgM by ELISA Susceptibility